# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009044
Filing Date
2025-05-07
Accepted
2025-05-07 16:30:52
Documents
76
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 646087
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 11552
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 11725
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 6774
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 6926
6 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 5675
| Complete submission text file | 0001641172-25-009044.txt |  | 4600141

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | erna-20250331.xsd | EX-101.SCH | 40154
8 | XBRL CALCULATION FILE | erna-20250331_cal.xml | EX-101.CAL | 63195
9 | XBRL DEFINITION FILE | erna-20250331_def.xml | EX-101.DEF | 175873
10 | XBRL LABEL FILE | erna-20250331_lab.xml | EX-101.LAB | 351621
11 | XBRL PRESENTATION FILE | erna-20250331_pre.xml | EX-101.PRE | 308207
78 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 499844

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 25921954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)